Crestline Management’s Inogen INGN Stock Holding History

Crestline Management’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18,000	Closed	-$612K	–	294
2021 Q4	$612K	Buy	+18,000	New	+$654K	0.05%	153

Other funds holding INGN

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Crestline Management's INGN Position: Q1 2022 in Review

Crestline Management sold out of Inogen (INGN) in Q1 2022, closing a stake of 66,725 shares — an estimated $2.27M sold.

Crestline Management first reported a position in INGN in Q3 2021 and held it in 2 quarters. The position peaked at $2.27M in Q4 2021. 149 funds tracked by Wall St. Rank hold INGN as of Q1 2022.

Crestline Management reported no remaining Inogen position as of Q1 2022 after selling out during the quarter.
Crestline Management sold 66,725 Inogen shares in Q1 2022, an estimated $2.27M.
Crestline Management first reported a position in Inogen in Q3 2021 and held it in 2 quarters.
Crestline Management's Inogen position peaked at $2.27M in Q4 2021.
149 funds tracked by Wall St. Rank held Inogen as of Q1 2022.

Based on Crestline Management's 13F filing for Q1 2022, filed 16 May 2022.